Back to Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
1,951 Dovepress* 1,251 188+ 604 1,439
PubMed Central* 0 512 133 512
Totals 1,251 700 737 1,951
*Since 26 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar